Described herein are pharmaceutical packaging units which stop oxidative degradation of morphine, hydromorphone, promethazine and also other oxygen-delicate medications, these kinds of programs which includes a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with incredibly minimal permeability to ox